Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5289823
Chembl Id: CHEMBL5289823
Max Phase: Preclinical
Molecular Formula: C36H54N4O9
Molecular Weight: 686.85
Associated Items:
ID: ALA5289823
Chembl Id: CHEMBL5289823
Max Phase: Preclinical
Molecular Formula: C36H54N4O9
Molecular Weight: 686.85
Associated Items:
Canonical SMILES: CO[C@H]1[C@@H](OC)C[C@H](C)[C@@H](OC)C2=CC(=O)C(N3CCN(C)CC3)=C(NC(=O)/C(C)=C/C=C\[C@H](OC)[C@H](OC(N)=O)C3(C)CC3[C@@H]1C)C2=O
Standard InChI: InChI=1S/C36H54N4O9/c1-20-11-10-12-26(45-6)33(49-35(37)44)36(4)19-24(36)22(3)32(48-9)27(46-7)17-21(2)31(47-8)23-18-25(41)29(28(30(23)42)38-34(20)43)40-15-13-39(5)14-16-40/h10-12,18,21-22,24,26-27,31-33H,13-17,19H2,1-9H3,(H2,37,44)(H,38,43)/b12-10-,20-11+/t21-,22-,24?,26-,27-,31+,32+,33-,36?/m0/s1
Standard InChI Key: GAMTXFZGUUHNTQ-NNBGOMFZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 686.85 | Molecular Weight (Monoisotopic): 686.3891 | AlogP: 2.37 | #Rotatable Bonds: 6 |
Polar Surface Area: 158.96 | Molecular Species: NEUTRAL | HBA: 11 | HBD: 2 |
#RO5 Violations: 2 | HBA (Lipinski): 13 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 12.58 | CX Basic pKa: 5.98 | CX LogP: 2.28 | CX LogD: 2.27 |
Aromatic Rings: 0 | Heavy Atoms: 49 | QED Weighted: 0.40 | Np Likeness Score: 1.70 |
1. Gomes AR, Varela CL, Tavares-da-Silva EJ, Roleira FMF.. (2020) Epoxide containing molecules: A good or a bad drug design approach., 201 [PMID:32526552] [10.1016/j.ejmech.2020.112327] |
Source(1):